19 companies · 10 head-to-heads
Every clinical trial patient recruitment company, described the way a coordinator would describe them.
Who they actually are, what they are good at, where they fall over, and who they lose to. No sponsored tiers, no vendor-written copy, no five-star everything.
Start with a comparison
Most people arrive here already paying someone and quietly wondering whether the other option would have been better.
AutoCruitment vs Antidote
Paid-media volume versus advocacy-sourced quality.
AutoCruitment vs Clara Health
Referral volume versus navigated conversion.
Science 37 vs Curavit
Two decentralized models at different scales.
Lindus Health vs TrialSpark
Bundled fixed-price CRO versus technology-led execution.
Deep 6 AI vs Citeline
Patient-level record mining versus market-level trial data.
Elligo Health Research vs Acurian
Community practice records versus consumer-data outreach.
By what you are actually running
Patient recruitment companies for rare disease
In rare disease the addressable population may be a few thousand people worldwide, so cost-per-click logic collapses. The vendors that work here reach patients through advocacy communities, treating specialists, and record mining rather than broad advertising.
Oncology patient recruitment companies
Oncology eligibility lives in pathology reports, biomarker panels, and prior-line history — most of it unstructured. Identification technology and site-side workflow matter more than consumer advertising.
Decentralized clinical trial recruitment companies
Decentralized and hybrid designs remove geography as an enrollment ceiling, but only for protocols whose assessments can genuinely be done remotely. Assess the protocol before you assess the vendor.
Site networks and record-based enrollment
Instead of finding patients and sending them to sites, these models start from patients who are already inside a care relationship or a health record system.